Position in HOOK
as of Sep 30, 2025
· filed Nov 14, 2025
Position Value
$0
+$0 QoQ
Shares Held
498,625
0.0% QoQ
Ownership
4.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HOOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Knoll Capital Management, LLC holds $72,284,754 across 10 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGTX |
MeiraGTx Holdings plc
|
1,250,000 | $16,887,500 | |
| 2 | ALDX |
Aldeyra Therapeutics, Inc.
|
5,475,516 | $11,662,849 | |
| 3 | OCUL |
Ocular Therapeutix, Inc
|
1,150,400 | $11,296,928 | |
| 4 | ENTX |
Entera Bio Ltd.
|
5,881,879 | $10,410,925 | |
| 5 | NUVB |
Nuvation Bio Inc.
|
1,598,591 | $9,079,996 | |
| 6 | ELTX |
Elicio Therapeutics, Inc.
|
1,211,957 | $4,738,751 | |
| 7 | ABVX |
Abivax S.A.
|
35,000 | $4,664,100 | |
| 8 | ABEO |
Abeona Therapeutics Inc.
|
485,515 | $3,000,482 |
All Filings in HOOK
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 | — | 498,625 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | — | 498,625 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | — | 498,625 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | — | 498,625 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | — | 551,738 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | — | 5,517,385 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | — | 5,517,385 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | — | 5,517,385 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | — | 5,517,385 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | — | 5,517,385 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | — | 300,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | — | 50,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||